NCT02240719 2019-01-04Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic CancerUniversity of California, DavisPhase 1 Completed20 enrolled
NCT01334502 2017-08-10Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell LymphomaAlliance for Clinical Trials in OncologyPhase 1 Completed26 enrolled
NCT00671112 2015-10-28Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaCase Comprehensive Cancer CenterPhase 1 Terminated30 enrolled
NCT00352443 2015-03-06S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaSWOG Cancer Research NetworkPhase 1 Completed66 enrolled
NCT00962507 2013-02-15Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaCity of Hope Medical CenterPhase 1 Completed11 enrolled